Through mutation screening in patients with DC and related bone marrow failure syndromes, we have identified 23 novel mutations in core components of telomerase: 11 in TERC, 8 in TERT and 4 in DKC1 (Table 1, Figures S1 and S2). This evidence concerns the gene TERC and dyskeratosis congenita.